Computational Drug Screening in COVID-19 Drug Repurposing Research: Encouraging Findings and Limitations

Απόστολος Ζάρρος

doi:10.14218/jerp.2021.00061

ScienceGate Book Chapters

JOURNAL ARTICLE

Computational Drug Screening in COVID-19 Drug Repurposing Research: Encouraging Findings and Limitations

Απόστολος Ζάρρος

Year: 2022 Journal: Journal of Exploratory Research in Pharmacology Vol: 7 (1)Pages: 3-4

DOI: 10.14218/jerp.2021.00061

Get Full-Text PDF Get Analytical Report

Keywords:

Drug repositioning Coronavirus disease 2019 (COVID-19) Repurposing Drug Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 2019-20 coronavirus outbreak Medicine Drug discovery Pharmacology Virology Bioinformatics Internal medicine Infectious disease (medical specialty) Biology

Metrics

Cited By

0.26

FWCI (Field Weighted Citation Impact)

Refs

0.44

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Computational Drug Discovery Methods

Physical Sciences → Computer Science → Computational Theory and Mathematics

Cell Image Analysis Techniques

Life Sciences → Biochemistry, Genetics and Molecular Biology → Biophysics

Cancer Genomics and Diagnostics

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Computational Drug Screening in COVID-19 Drug Repurposing Research: Encouraging Findings and Limitations

Metrics

Citation History

Topics

Related Documents

Computational Intelligence in Drug Repurposing for COVID-19

Drug Repurposing for COVID-19 using Computational Methods

Computational-based drug repurposing methods in COVID-19

Drug Repurposing and Computational Drug Discovery for Viral Infections and COVID-19

Drug Repurposing for COVID 19